XLY News Alert Consumer Discret Select Sector SPDR (XLY) 69.33

New Post Public Reply Private Reply Replies (0) Message Board

Nov 18, 2014 at 11:08 PM

Consumer Discret Select Sector SPDR (XLY) 69.33 $XLY

XLY: Profiting From The Upcoming Christmas Spending Surge
FX Analyst - at Seeking Alpha - Sun Nov 16, 5:37AM CST

XLY: 69.33 (+0.13)

Retail ETFs Hitting Highs Ahead Of Holidays
Benzinga - Seeking Alpha - Fri Nov 14, 4:34PM CST
By Matthew McCall The retail sector is on fire with many of its biggest names trading at or near new yearly highs. Heading into the most lucrative part of the year for retailers, they will be looking to make the most of this holiday season and...
XLY: 69.33 (+0.13), RTH: 67.49 (+0.15)

Comparing America's 3 Largest Apparel Clothing Companies
Joseph Cafariello - at Seeking Alpha - Tue Nov 11, 8:05AM CST

UA: 69.37 (+0.48), XLY: 69.33 (+0.13), HBI: 110.43 (+0.24), RL: 176.56 (+0.51)

Defensive Leadership: A Showstopper For Bull Market?
Chris Ciovacco - Seeking Alpha - Mon Nov 10, 2:56PM CST
Consumer Discretionary Underperforming The chart below shows the performance of consumer discretionary stocks (NYSEARCA: XLY ) relative to consumer staples (NYSEARCA: XLP ). For most of 2013, discretionary sectors were leading defensive sectors...
XLP: 48.26 (+0.18), SPY: 205.55 (+1.18), XLY: 69.33 (+0.13), PG: 87.95 (+0.11), TLT: 119.52 (+0.33)

Will Disney Earnings Drag Down Consumer Discretionary ETFs? - ETF News And Commentary
Zacks Equity Research - ZACKS - Mon Nov 10, 11:00AM CST
Should investors be worried about consumer ETFs following just an OK earnings report from Disney?
PBS: 25.05 (+0.13), VCR: 113.35 (+0.26), XLY: 69.33 (+0.13), DIS: 90.28 (-0.13)

Are We On The Brink Of A Bear Market?
Jaimini Desai - Amigobulls - Sun Nov 09, 11:00PM CST
Some market indicators bring back memories of the bear market in 2011 and raise the question, are be on the bring of a bear market?
XLY: 69.33 (+0.13)

The Best Offense Is A Good Defense
Eric Parnell, CFA - Seeking Alpha - Sat Nov 08, 8:36AM CST
What a difference a few weeks make. Stocks are once again in rally mode and bullishness is back on the street. After bottoming back on October 15, stocks as measured by the S&P 500 Index have rallied an impressive +11.6% to advance to fresh new...
XLB: 49.87 (+0.59), BDX: 130.94 (+1.40), SPLV: 37.14 (+0.15), DAL: 44.79 (+1.36), XLY: 69.33 (+0.13), BBY: 34.90 (-0.39), XLU: 45.66 (+0.13), SO: 47.25 (+0.17), XLV: 68.67 (+1.09), YHOO: 51.75 (-0.62), XLP: 48.26 (+0.18), SPY: 205.55 (+1.18), SPHB: 34.46 (+0.36), XLK: 41.67 (+0.14), PG: 87.95 (+0.11), XLI: 56.65 (+0.42), XLE: 85.83 (+0.07)

Pause For A Cause: A 3-Month Outlook On The S&P 500 And U.S. 10-Year Yield
Cerebro1 - at Seeking Alpha - Wed Nov 05, 2:44PM CST

SPY: 205.55 (+1.18), IEF: 105.10 (+0.12), XLY: 69.33 (+0.13), XLK: 41.67 (+0.14), XLI: 56.65 (+0.42), XLU: 45.66 (+0.13), XLF: 24.14 (+0.08), XLV: 68.67 (+1.09)

A Valuation Snapshot By Sectors
Fred Piard - at Seeking Alpha - Wed Nov 05, 9:09AM CST

XLB: 49.87 (+0.59), XLP: 48.26 (+0.18), XLY: 69.33 (+0.13), XLK: 41.67 (+0.14), XLI: 56.65 (+0.42), XLU: 45.66 (+0.13), XLF: 24.14 (+0.08), XLV: 68.67 (+1.09), XLE: 85.83 (+0.07)

Amazon calls November 1st start of holiday deal season
Seeking Alpha - at Seeking Alpha - Fri Oct 31, 1:12PM CDT

IYK: 104.94 (+0.49), AMZN: 324.93 (+1.88), SCC: 14.55 (-0.05), XLY: 69.33 (+0.13), IYC: 131.10 (+0.52), RTH: 67.49 (+0.15), XRT: 90.37 (+0.09), FDIS: 28.09 (+0.08), VCR: 113.35 (+0.26), PMR: 36.04 (+0.08), UGE: 96.87 (+1.62), RETL: 87.45 (-0.29), SZK: 27.04 (-0.28), UCC: 88.20 (-0.08), RCD: 84.62 (+0.34), FXD: 34.29 (+0.15)

Goldilocks Opportunity To Invest In S&P 500 Ahead Of Historic FOMC Meeting
FX Analyst - at Seeking Alpha - Thu Oct 30, 7:05AM CDT

SPY: 205.55 (+1.18), XLY: 69.33 (+0.13)

Are XLY And Consumer Discretionary Overpriced?
Fred Piard - at Seeking Alpha - Thu Oct 30, 1:31AM CDT

SBUX: 77.57 (-0.26), AMZN: 324.93 (+1.88), HD: 95.98 (-2.05), NKE: 96.47 (+0.41), XLY: 69.33 (+0.13), FOXA: 35.30 (-0.04), MCD: 96.41 (+0.44), DIS: 90.28 (-0.13), CMCSA: 54.42 (+0.27), PCLN: 1,166.83 (+0.42), TWX: 80.50 (+0.10)

As The Market Rebounds, 2 Opportunities Bubble To Top
Russ Koesterich, CFA - Seeking Alpha - Wed Oct 29, 1:30AM CDT
What a difference a week makes. After a significant sell-off the week before, stocks staged a strong rebound last week. Now, with a seeming shift in sentiment, where do we see value in the market as we look ahead? As I write in this week’s...
JPNL: 44.82 (+1.63), XLY: 69.33 (+0.13), JPNS: 24.62 (+0.12), RTH: 67.49 (+0.15), XRT: 90.37 (+0.09), EWJ: 11.74 (+0.16), DXJ: 54.64 (+0.77), NKY: 17.71 (+0.18), EWV: 61.25 (-1.67), FDIS: 28.09 (+0.08), VCR: 113.35 (+0.26), HEWJ: 27.93 (+0.47), PMR: 36.04 (+0.08), ITF: 50.17 (+0.62), DBJP: 41.03 (+0.69), RETL: 87.45 (-0.29), JPP: 45.14 (+0.66), RCD: 84.62 (+0.34), FXD: 34.29 (+0.15), EZJ: 83.43 (+2.20), FJP: 45.26 (+0.52)

Consumer Discretionary ETFs After Weak Fast Food Earnings - ETF News And Commentary
Zacks Equity Research - Zacks Investment Research - Thu Oct 23, 1:00PM CDT
How Q4 is shaping up for consumer funds following earnings from CMG and MCD.
PEJ: 34.07 (+0.16), VCR: 113.35 (+0.26), CMG: 658.09 (-0.23), XLY: 69.33 (+0.13), MCD: 96.41 (+0.44)

Consumer Discretionary ETF: No. 9 Select Sector SPDR Over 2014's First 9 Months
J.J. McGrath - at Seeking Alpha - Sat Oct 18, 11:12PM CDT

XLP: 48.26 (+0.18), SPY: 205.55 (+1.18), XLY: 69.33 (+0.13), XLU: 45.66 (+0.13), XLV: 68.67 (+1.09)

Accenture: Discounts to rule holiday season
Seeking Alpha - at Seeking Alpha - Fri Oct 17, 2:03PM CDT

FDIS: 28.09 (+0.08), PEJ: 34.07 (+0.16), VCR: 113.35 (+0.26), PMR: 36.04 (+0.08), RETL: 87.45 (-0.29), XLY: 69.33 (+0.13), RCD: 84.62 (+0.34), FXD: 34.29 (+0.15), RTH: 67.49 (+0.15), PEZ: 43.05 (+0.41), XRT: 90.37 (+0.09), PSCD: 48.10 (+0.13)

How the Ebola Scare Could Affect Holiday Shopping This Year
at The Street - Fri Oct 17, 10:51AM CDT
If worries about Ebola continue to spread, more U.S. consumers may decide to skip the mall altogether and do more of their holiday shopping online this year.
FDX: 172.00 (+0.68), AMZN: 324.93 (+1.88), MAT: 30.90 (+0.07), DAL: 44.79 (+1.36), ANF: 28.94 (-0.24), XLY: 69.33 (+0.13), TGT: 67.51 (+0.38), WMT: 83.79 (+0.22), HBI: 110.43 (+0.24), GPS: 39.35 (+0.08), XRT: 90.37 (+0.09)

NPD Group: Here come the deal-savvy holiday shoppers
Seeking Alpha - at Seeking Alpha - Wed Oct 15, 1:29PM CDT

FDIS: 28.09 (+0.08), VCR: 113.35 (+0.26), PMR: 36.04 (+0.08), RETL: 87.45 (-0.29), XLY: 69.33 (+0.13), RCD: 84.62 (+0.34), FXD: 34.29 (+0.15), RTH: 67.49 (+0.15), XRT: 90.37 (+0.09)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Borr Drilling's Rig Sinks, Uncertainty Looms Offshore

Unexpected Turn of Events at Sea Now here's a gut-punch nobody saw coming. Borr Drilling Limited (NYSE and OSE: BORR) got hit hard when their Prospector 5 drilling rig went under the waves offshore Gabon. This ain't no desk job dilemma; we're talking about a real-life offshore catastrophe. It all went down on October 24, 2026, when the rig experienced a punch through...

Lilly's Olomorasib: New Data Sparks Hope for G12C NSCLC

New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...

Amgen's IMDELLTRA® Shows Promise in SCLC Battle

Breakthrough Results in SCLC Treatment For years, small cell lung cancer (SCLC) has been the unruly beast in the oncology world, defying treatment advances and keeping survival rates stubbornly low. This nasty foe might just have met its match, folks. Amgen (NASDAQ:AMGN) announced results from their Phase 3 DeLLphi-305 trial that show their drug IMDELLTRA®, when teamed...

Survivors Secure $800M Settlement with NY Archdiocese

Massive Settlement: A Long-Awaited Justice Here's a different kind of news that's hitting like a thunderbolt. Over 1,300 survivors of abuse have finally struck a landmark deal with the Archdiocese of New York. Not only are the numbers staggering, but the relief for these individuals is palpable. We're talking about more than $800 million on the table here. That's some...

Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

TORRAS Cases Balance Protection with Slim Design for 2026

Are Slim iPhone Cases Really Protecting Your Investment? Anyone who's dropped a brand-new phone knows the pain of watching your investment smack the concrete. But hey, welcome to 2026, where Consumer365's latest rundown on iPhone protective gear turns the spotlight on TORRAS. These folks grabbed attention with their Q3 Air and Q3 Air Pro cases, crafted for iPhone 18 Pro...

Alaska's Insurance Maze: Coverage Over Cheap Policies

Beyond Premiums: Assessing Real Coverage Needs The Alaskan wilderness isn't just home to stunning views; it's also a land where insurance needs to go beyond the average cookie-cutter policy. You'd think the cheapest option would suffice, but that's where residents might trip into financial quicksand. Devery Prince, a seasoned insurance principal, sheds light on why...

CSTS Unveils PremierX in NYC: A Bold Entertainment Move

Welcome to the New Era of Entertainment Out of the blockbusters and into the open air, eh? On October 30, 2026, CSTS Enterprises flipped the New York skyline into a canvas for their grand kickoff of PremierXTM—a live entertainment brand poised to redefine how we gobble up our music, sport, and art. Now, there's a shot of adrenaline New Yorkers weren't exactly begging...

Axon Body 5: A Leap Forward in AI for Public Safety

Axon Raises the Stakes with Body 5 Camera Boy, oh boy, Axon's dropped a bombshell with the Body 5. We're talking a colossal leap into the AI era for public safety, and if you're in the biz, you can't just shrug this one off. We're looking at 25 times the AI processing power compared to Axon's old units. That's right, I said twenty-five. Real-time situational awareness in...

Innovent's IBI354: New Data Spurs Hope for HER2+ BC

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...